Jiangtao Ren
- Oncology top 2%
- CAR-T cell therapy research 10
- Genetics top 2%
- Virus-based gene therapy research 3
- Animal Genetics and Reproduction 2
- Immunology top 5%
- Molecular Biology top 5%
- CRISPR and Genetic Engineering 12
- Pluripotent Stem Cells Research 5
- Viral Infectious Diseases and Gene Expression in Insects 3
-
- Tissue Engineering and Regenerative Medicine 2
-
- Nanowire Synthesis and Applications 2
Jiangtao Ren
15 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 1.5k
- Business and International Management 65
- Genetics 769
- Immunology 523
- Molecular Biology 1.4k
Countries citing papers authored by Jiangtao Ren
This map shows the geographic impact of Jiangtao Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangtao Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangtao Ren more than expected).
Fields of papers citing papers by Jiangtao Ren
This network shows the impact of papers produced by Jiangtao Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangtao Ren. The network helps show where Jiangtao Ren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiangtao Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 22 | |
| 4 | CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemiabreakdown → | 2021 | 202 |
| 5 | 2020 | 13 | |
| 6 | 2018 | 15 | |
| 7 | Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18breakdown → | 2017 | 400 |
| 8 | 2017 | 315 | |
| 9 | 2017 | 82 | |
| 10 | Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibitionbreakdown → | 2016 | 738 |
| 11 | 2015 | 12 | |
| 12 | 2013 | 59 | |
| 13 | 2012 | 28 | |
| 14 | 2011 | 93 | |
| 15 | 2009 | 291 |
About Jiangtao Ren
Jiangtao Ren is a scholar working on Business and International Management, Oncology and Molecular Biology, having authored 15 papers that have together received 2.3k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (12 papers), CAR-T cell therapy research (10 papers), Pluripotent Stem Cells Research (5 papers), Virus-based gene therapy research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Tissue Engineering and Regenerative Medicine (2 papers), Nanowire Synthesis and Applications (2 papers) and Animal Genetics and Reproduction (2 papers). The work is most often cited by research in Oncology (1.5k citations), Business and International Management (65 citations) and Genetics (769 citations). Jiangtao Ren has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yangbing Zhao, Carl H. June, Xiaojun Liu, Shuguang Jiang, Chongyun Fang, Yanping Luo, Brian Keith, Regina M. Young, John Scholler and Biliang Hu. Their work appears in journals such as Blood, Clinical Cancer Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.